Rocket Lab Corporation
Adam C. Spice (Chief Financial Officer) sells RKLB shares
AI-generated summary
Chief Financial Officer Adam C. Spice exercised options for 140,157 shares of Common Stock at an average price of $1.09, totaling $152,771.13. Adam C. Spice also sold 140,157 shares of Common Stock in open-market sales at an average price of $52.79, totaling $7,398,440.41, under a Rule 10b5-1 trading plan adopted on June 3, 2026. Following these transactions, Adam C. Spice directly held 1,155,967 shares of Common Stock.
Key facts
- Insider
- Adam C. Spice · Chief Financial Officer
Rule 10b5-1 plan · adopted Jun 3, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | M · exercise or conversion of a derivative | +140,157 | $1.09 | $152,771.13 | 1,296,124 | Direct |
| Nov 2, 2026 | S · open-market saleFootnotes F1, F2 | −47,554 | $51.28 | $2,438,588.14 | 1,248,570 | Direct |
| Nov 2, 2026 | S · open-market saleFootnotes F1, F3 | −14,266 | $52.26 | $745,595.37 | 1,234,304 | Direct |
| Nov 2, 2026 | S · open-market saleFootnotes F1, F4 | −33,681 | $53.29 | $1,794,806.60 | 1,200,623 | Direct |
| Nov 2, 2026 | S · open-market saleFootnotes F1, F5 | −37,950 | $54.07 | $2,052,062.76 | 1,162,673 | Direct |
| Nov 2, 2026 | S · open-market saleFootnotes F1, F6 | −6,706 | $54.78 | $367,387.54 | 1,155,967 | Direct |
| Nov 2, 2026 | M · exercise or conversion of a derivativeEmployee Stock Option (right to buy)Footnotes F7 | −140,157 | $0.00 | $0.00 | 2,102,354 | Direct |
Footnotes
- F1 Represents the sale of shares which occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 03, 2026.
- F2 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $50.7100 to $51.7000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $51.7100 to $52.7000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $52.7100 to $53.7000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $53.7100 to $54.7000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $54.7100 to $55.0000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7 The stock option was granted on August 3, 2018, and had a vesting commencement date of May 25, 2018. 1/4 of the shares subject to the stock option vest on the one year anniversary of the vesting commencement date, and 1/48 of the shares subject to the stock option vest on a monthly basis each month thereafter, subject, in each case, to the reporting person's continued service relationship through each applicable vesting date.
More RKLB filings
- 4
Filed Nov 3, 2026
- 144
Filed Nov 2, 2026
- 144
Filed Nov 2, 2026
- 8-K
Filed Oct 14, 2026
- 4
Filed Oct 2, 2026
- 144
Filed Oct 1, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.